KatGuide Method Versus Conventional Method at Insertion of Chest Tube

Sponsor
Niels Katballe (Other)
Overall Status
Completed
CT.gov ID
NCT01522885
Collaborator
University of Aarhus (Other)
109
4
2
25
27.3
1.1

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate whether if KatGuide (a new developed medical device) improves the placing of a large bore chest tube in the pleural cavity compared to the conventional method.

Condition or Disease Intervention/Treatment Phase
  • Device: KatGuide versus conventional method (forceps)
  • Procedure: Chest tube insertion
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
109 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
KatGuide-trial. KatGuide Method Versus Conventional Method at Insertion of Chest Tube. A Randomized, Parallel Group, Controlled Trial.
Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
May 1, 2014
Actual Study Completion Date :
May 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: KatGuide

Chest tube insertion is performed by using the KatGuide

Device: KatGuide versus conventional method (forceps)
According to randomization Chest tubes are placed in the pleural cavity by using the KatGuide device.

Active Comparator: Conventional group

Chest tubes are inserted by using conventional method (forceps) for large bore chest tube insertion.

Procedure: Chest tube insertion
The chest tube is placed in the pleural cavity by using a forceps (conventional method) or KatGuide

Outcome Measures

Primary Outcome Measures

  1. Chest tube placement [3 hours]

    X-ray examination of the chest is performed within 3 hours after the chest tube insertion, to evaluate if the placement of the chest tube is acceptable.

Secondary Outcome Measures

  1. Length of hospital stay [5 days]

    The hospital stay depends on how long time it takes to solve the chest tube related problem. In a few patients it takes only one day, but in severe cases it may take weeks before the patient can be discharged. We predict, that the patient will be in hospital for a mean time of 5 days.

  2. Time with chest tube [3 days (mean time)]

    A few patients can have the chest tube removed in only one day, but some patients must have a chest tube for weeks. We predict that the patients will have a chest tube in a mean time of 3 days.

  3. Infection in wound [4 weeks]

    4 weeks after the chest tube insertion, the patient is contacted and the patient is asked whether there are problems with infection of the wound.

  4. Number of chest tubes [7 days (mean time)]

    It is observed whether the patient has multiple chest tubes inserted in the pleural cavity at the same side. It is predicted, that these patients are hospitalized longer than patients with only one chest tube. We predict, that these patients are hospitalized for a mean time of 7 days.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with pneumothorax in the upper pleural space or fluid in the lower pleural space.

  • Indication for upper or lower placement of a single chest tube in the pleural cavity

  • 18 years of age or older

Exclusion Criteria:
  • Fertile women

  • Patients who can not give written or verbal consent to participate

  • If there is no time or possibility to inform the patient

  • Patients who already has a large bore chest tube

  • Patients with long lasting (>14 days) or chronic chest tube

  • Patients with both fluid and air in the pleural cavity

  • Patients where "the safe area" (front axillary fold, IC 4-5) can not be used for chest tube insertion

Contacts and Locations

Locations

Site City State Country Postal Code
1 Niels Katballe Aarhus Aarhus N Denmark 8200
2 Vytautas Nekrasas Aalborg Denmark 9000
3 Niels Katballe Aarhus N Denmark 8200
4 Peter B Licht Odense Denmark 5000

Sponsors and Collaborators

  • Niels Katballe
  • University of Aarhus

Investigators

  • Study Director: Niels Katballe, MD, PhD, University of Aarhus

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Niels Katballe, Coordinating investigator, MD, PhD, University of Aarhus
ClinicalTrials.gov Identifier:
NCT01522885
Other Study ID Numbers:
  • 2011375
First Posted:
Feb 1, 2012
Last Update Posted:
Aug 21, 2014
Last Verified:
Aug 1, 2014
Keywords provided by Niels Katballe, Coordinating investigator, MD, PhD, University of Aarhus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2014